Can behavioural activation be used as an alternative treatment for subthreshold depression in type 2 diabetes? by Hardy,  S. et al.
Durham Research Online
Deposited in DRO:
17 June 2016
Version of attached ﬁle:
Published Version
Peer-review status of attached ﬁle:
Peer-reviewed
Citation for published item:
Hardy, S. and Al Shamari, B.K. and Al-Mutawa, M.N.Q.H. and Mathias, J. and Ekers, D. and Gellatly, J. and
Figgins, N. and Gray, R. (2015) 'Can behavioural activation be used as an alternative treatment for
subthreshold depression in type 2 diabetes?', Mental health and family medicine., 11 (2). pp. 49-52.
Further information on publisher's website:
http://www.mhfmjournal.com/mental-health/can-behavioural-activation-be-used-as-an-alternative-treatment-
for-subthreshold-depression-in-type-2-diabetes.php?aid=7547
Publisher's copyright statement:
This article is licensed under a Creative Commons Attribution 4.0 International License.
Additional information:
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for
personal research or study, educational, or not-for-proﬁt purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in DRO
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full DRO policy for further details.
Durham University Library, Stockton Road, Durham DH1 3LY, United Kingdom
Tel : +44 (0)191 334 3042 | Fax : +44 (0)191 334 2971
http://dro.dur.ac.uk
Research Article Open Access
Mental Health in Family Medicine 2015; 11:49-52
Research Article
2015 Mental Health and Family Medicine Ltd
Can Behavioural Activation Be Used As An Alternative 
Treatment For Subthreshold Depression In Type 2 
Diabetes?
Sheila Hardy
Senior Research Fellow, Northamptonshire Healthcare NHS Foundation Trust; Honorary Senior Lecturer, UCL, UK
Badriya Khalifa Al Shamari
Director of Nursing, Hamad Medical Corporation, Qatar
Mariam Nooh Q.H. Al-Mutawa
Executive Director of Nursing, Hamad Medical Corporation, Qatar
Jesveena Mathias
Nurse Educator, Hamad Medical Corporation, Qatar
David Ekers
Senior Lecturer Psychological Therapy Research, Mental Health Research Group, School of Medicine,  Pharmacy and Health Durham 
University; Nurse Consultant, Tees Esk and Wear Valleys NHS FT, UK
Judith Gellatly
Research Fellow, The University of Manchester, UK
Natalie Figgins
Assistant Area Team Manager, Central East Community Mental Health Team, Manchester Mental Health and Social Care Trust, UK
Richard Gray
Professor and Assistant Executive Director – Research, Hamad Medical Corporation; University of South Australia
Subthreshold depression is common in people with type 
2 diabetes and is an important risk factor for poor health. 
Collaborative care is the suggested approach for people with 
long term conditions and persistent subthreshold depression, 
with a high-intensity psychological intervention being the 
recommended treatment. However, there is little evidence 
that a high-intensity psychological intervention improves 
subthreshold depression in people with type 2 diabetes. 
Additionally, its use as a treatment in day to day practice can be 
difficult and expensive to organise even when a collaborative 
care approach is utilised. Behavioural activation delivered 
by the patients’ usual diabetes care giver as a treatment for 
subthreshold depression could be an effective alternative.
MeSH Headings/Keywords: Subthreshold depression, 
diabetes.
AbSTRACT
Introduction 
Type 2 diabetes is a prevalent long term condition. To 
control their condition well, people with diabetes need to learn 
how to self-manage their lifestyle behaviours [1]. Depression 
is common in people with diabetes [2]. This co-morbidity 
can lead to significantly poorer health outcomes and reduced 
quality of life [3]. People with both diabetes and depression are 
more likely to have poor control of their glycated haemoglobin 
and are less likely to eat a healthy diet, exercise and take 
their prescribed medication compared with those who are not 
depressed [4]. They are also more at risk of developing adverse 
complications of diabetes, for example microvascular and 
macrovascular disease [5]. Therefore, populations at high risk 
of depression, such as those with diabetes, should be screened 
for depression and offered treatment [6].  There is evidence to 
suggest that the effectiveness of depression treatments is poorer 
in people with diabetes compared with those who do not have 
diabetes [7]. Total health care costs might be increased by up 
to 45% for each person because of a long-term condition and 
co-morbid mental health problem.  The aim of this paper is to 
look at whether behavioural activation could be an alternative 
to high-intensity psychological interventions as a treatment for 
subthreshold depression in people with diabetes.
Subthreshold depression and diabetes: People with sub-
threshold depression will have experienced more than two 
and less than five depressive symptoms which are present 
most or all of the time, for at least 2 weeks in duration, and 
be associated with evidence of social dysfunction [8]. These 
symptoms are the same as those identified by the criteria as 
defined by DSM-V for major depression where at least five 
out of nine depression symptoms need to be present [9]. It is 
thought around eight percent of people with subthreshold 
depression progress to major depression within two years of 
developing symptoms [10,11] carried out a meta-analysis of 
42 published studies that included 21,351 adults with diabetes. 
They found the prevalence of mild or subthreshold depression 
was 20% compared to nine percent of those without diabetes. In 
practice this means that out of every five patients with diabetes, 
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one will have mild or subthreshold depression [12]. Using this 
information, the number of people with diabetes who may 
have mild/subthreshold depression can be calculated in each 
country. For example, in the United Kingdom the population 
is 64,100,000 [13] and the prevalence of diabetes is 4.5%; so 
there are 2,884,500 people with diabetes of which 576,900 are 
likely to have mild/subthreshold depression. It is estimated that 
8.5% of world’s population (360 million people) are living with 
diabetes [14], accordingly that’s 72 million people who have 
diabetes and mild/subthreshold depression in the world.
Despite subthreshold depression being so prevalent in type 
2 diabetes, it is often overlooked by clinicians [15]. This has 
implications for patients. A prospective community study of 
1,064 patients with type 2 diabetes concluded that recurrent 
subthreshold depression could be an important risk factor for 
poor health outcomes in this group [16]. The authors recommend 
early treatment of recurrent subthreshold depressive symptoms 
to improve functioning and quality of life in people with type 
2 diabetes. 
Managing subthreshold depression: In a study comparing 
the health care systems of the 11 wealthiest countries, the United 
Kingdom (UK) was shown to be the best at managing physical 
and mental long term conditions. Healthcare professionals in 
the UK follow national guidelines for individual conditions 
to inform them in the delivery of care. There is guidance for 
the treatment and management of depression in adults with a 
chronic physical health problem [17]. The authors recommend 
collaborative care as an approach and psychological therapy as 
a treatment for people with persistent subthreshold depressive 
symptoms. The psychological treatments recommended include 
individual guided self-help based on the principles of cognitive 
behavioural therapy (CBT) and computerised cognitive 
behavioural therapy (CCBT).
Collaborative care: Collaborative care is based upon an 
integrated care model which has been applied in the context of 
long-term conditions [18]. It is a multi-professional approach, 
requiring a general practitioner/family physician plus at least 
one other health professional [18]. There is little evidence 
that collaborative care is more effective than usual care for 
treating for subthreshold depression, but the evidence for its 
effectiveness in depression is robust [19]. However, in practice, 
there may be limited changes to processes of care if nurses and 
mental health professionals maintain their physical and mental 
health role boundaries [20,21]. Subthreshold depression may 
not be recognised by the nurse treating the patient’s diabetes 
and when it is, it may not be severe enough to meet the criteria 
for working with the mental health professional. The National 
Institute for Health and Care Excellence have not fully identified 
and defined key components of successful collaborative care 
for depression and long-term conditions. Components such as 
the category of the clinical staff or the type of therapy included 
may make a difference. A systematic review and meta-analysis 
of randomised trials of nurse-led management of depression 
in patients with long term health problems showed effect size 
of .43, reasoning that using nurses can play a significant role 
[22]. An effect size is a quantitative measure of the strength 
of an intervention [23]. The authors calculated this by using a 
computer programme with the value ranges of small (0–0.32), 
medium (0.33–0.55) and large (0.56 and above). Using a simple 
and straightforward therapy, such a behavioural therapy, as the 
psychological component of collaborative care may have a 
positive result.
High-intensity psychological interventions for people 
with diabetes and subthreshold depression: In England, high 
intensity psychological interventions are usually offered as 16-
20 sessions over six to nine months (as opposed to low intensity 
which is usually six to eight sessions over 10-12 weeks).  A 
meta-analysis of 18 studies (1913 participants) comparing a 
psychological treatment of subclinical depression with a control 
group, showed that psychological therapies may be effective in 
the treatment of subclinical depression in the general population, 
and may also reduce the incidence of major depressive disorder 
[24]. Commonly the psychological interventions used for 
depression is psychotherapy.  The purpose of psychotherapy is 
to look at worrying thoughts, feelings and behaviour to enable 
problem solving or improve symptoms. The therapy is usually 
delivered by a trained therapist who may be a CBT therapist, 
clinical psychologist, counsellor, nurse, occupational therapist, 
experienced graduate mental health worker or psychotherapist. 
In addition to their previous training they will have completed 
a one-year post-graduate diploma training programme and 
be accredited by the British Association of Behavioural and 
Cognitive Psychotherapies (BABCP). The most commonly 
used techniques are CBT (in depression this usually focuses 
on cognitive therapy where the person is encouraged to 
challenge their way of thinking to produce more helpful and 
realistic thought patterns), interpersonal therapy (IPT – the 
person is shown how to interact more effectively with others 
to improve their psychological symptoms), mindfulness-based 
cognitive therapy (combines the ideas of cognitive therapy 
with meditative practice) and counselling (allows the person 
to talk about their problems and feelings in a confidential and 
trustworthy environment).
There are only two studies that support psychological 
interventions as a treatment for subthreshold depression in 
people with diabetes [25] carried out an abridged Cochrane 
review to summarize and critically evaluate the effectiveness of 
psychological and pharmacological interventions for depression 
in patients with both diabetes and depression. Six randomized 
controlled trials investigated the effects of psychological 
interventions in depression, but only one specified that 
they included minor depression [26]. The authors found a 
considerable beneficial effect of a minimal psychological 
intervention compared with usual care on the level of depression. 
A randomized controlled trial published since the Cochrane 
review [27], tested a psychological intervention (CBT) in 
people with diabetes and subthreshold depression. They found 
significant improvement in depressive symptoms and the risk of 
incident major depression was reduced.  
Can behavioural activation be used as an alternative 
to high intensity psychological interventions?: Behavioural 
therapy is an alternative form of therapy used for depression, 
which is action based. The patient’s unhelpful behaviour 
is viewed as the problem and the goal is to encourage the 
development of new helpful behaviours to decrease the unhelpful 
ones. The authors of a Cochrane review of twenty-five trials 
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involving 955 participants [28] found low to moderate quality 
evidence that behavioural and other psychological therapies 
are equally effective. There is currently a trial in progress to 
measure the cost and outcome of one example of behavioural 
therapy (behavioural activation) versus CBT for depression 
[29].
There is some evidence to suggest that behavioural activation 
(BA) is an effective treatment for diagnosed depression [30,31]. 
It is a simple approach focussed upon identifying life changes 
that have a detrimental impact on psychologically healthy 
activities and is suitable for delivery by non-specialists.  A 
review of the empirical literature regarding BA has shown that 
activity monitoring and scheduling are constant components 
across interventions [32]. People with depression treated 
with CBT may also have the technique of activity monitoring 
and activity scheduling included in their treatment package, 
but these techniques are employed in the framework of a 
cognitive change model rather than the reinforcement-based 
model used in BA [33].  Reinforcement is defined generally 
as any environmental event that makes healthy, antidepressant 
behaviour more likely. The focus of BA is to take a pragmatic 
approach, looking at what predicts and maintains an unhelpful 
behaviour (for example avoiding exercise or taking prescribed 
medication) and prevents the person from reaching their goal 
[34]. The role of the therapist in BA is to encourage the person 
with depression to re-engage in activities, including those which 
increase experiences of pleasure and accomplishment, solve 
problems and are meaningful to that person.  When the person 
is deliberating, the therapist seeks to activate alternative healthy 
behaviours [35] plan to conduct a systematic review to clarify 
and further develop theoretical underpinnings for the use of BA 
interventions in depressed individuals with chronic physical 
illnesses, and to identify adaptations that have been made to BA 
interventions specifically for this population.
Discussion
National guidance in the UK recommends high-intensity 
psychological interventions for subthreshold depression in 
people with long term conditions. This is despite there being 
little evidence for people with diabetes that this therapy will 
improve the symptoms of depression [36,37]. High-intensity 
psychological interventions are typically delivered by mental 
health experts who usually only treat people with moderate to 
severe depression, and there are a large number of people with 
diabetes and subthreshold depression. Therefore its use as a 
treatment in day to day practice may be difficult and expensive 
to organise even when a collaborative care approach is utilised. 
Psychological interventions require an additional person to the 
one providing diabetes care. Apart from this being costly, there 
is the risk of delay or gaps in treatment. Increasing interactions 
between different professionals and patients may be seen by 
patients as complicating their illness management [38,39].
To manage their diabetes effectively, the patient is usually 
required to make changes to their lifestyle and to perform 
additional behaviours such as blood glucose monitoring and/
or taking medication. As BA is a brief intervention suitable for 
delivery by non-specialists, it could potentially be delivered by 
the patient’s usual diabetes care provider. The encouragement to 
engage in new helpful behaviours to improve health outcomes 
will then be provided by a healthcare professional who has an 
in-depth understanding of diabetes care. This would be part of 
the overall delivery of care and would not divide mental and 
physical treatments [40]. The advantage of this for the patient is 
that care delivery is uncomplicated and will not have the stigma 
attached to seeing a mental health professional [41]. Nurses 
delivering diabetes care can view the person as a whole and 
deliver BA in relation to the patient’s diabetes management as 
well as their symptoms of subthreshold depression. 
Conclusion
Few research studies have examined the effectiveness of 
psychological interventions on the treatment of subthreshold, 
rather than full symptom depression in patients with type 2 
diabetes. Behavioural activation delivered by the patients’ usual 
diabetes care giver may be an effective treatment to improve 
symptoms of subthreshold depression, glycaemic control, 
quality of life and healthcare costs.
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